Lineage Cell Therapeutics, Inc.LCTXNYSE
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$0.05
Net Income/Share$-0.30
Operating CF/Share$-0.09
Free CF/Share$-0.09
Cash/Share$0.18
Book Value/Share$0.09
Tangible Book/Share$-0.09
Equity/Share$0.10
Interest Debt/Share$0.01
CapEx/Share$0.00
Dividend/Share$0.00
Valuation
Market Cap$347.79M
Enterprise Value$309.95M
P/E Ratio-5.11P/S Ratio32.16P/OCF Ratio-16.95
P/FCF Ratio-16.66
P/B Ratio15.68P/TB Ratio15.68
EV/Sales28.66EV/EBITDA-6.79
Graham Valuation
Graham Number--
Graham Net-Net$-0.12
Profitability
Earnings Yield-19.58%FCF Yield-6.00%ROE-118.78%ROIC-43.26%Return on Tangible Assets-143.14%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF-2.39%
CapEx/Revenue4.51%
CapEx/Depreciation0.73
SBC/Revenue34.86%
SG&A/Revenue166.50%
R&D/Revenue119.40%
Liquidity & Solvency
Debt/Equity0.12Debt/Assets0.03Debt/Market Cap0.01
Net Debt/EBITDA0.83
Current Ratio4.50Interest Coverage0.00xIncome Quality0.30Efficiency
Days Sales Outstanding4 days
Days Payables Outstanding7097 days
Days Inventory0 days
Receivables Turnover85.17x
Payables Turnover0.05x
Inventory Turnover0.00x
Capital Structure
Tangible Assets-$21.58M
Working Capital$32.88M
Invested Capital$79.72M
Intangibles/Assets47.27%